NCT01849692View on ClinicalTrials.gov

ESBA1008 Microvolume Study

PHASE2CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Exudative Age-Related Macular Degeneration
Interventions
DRUG

ESBA1008 solution

Intravitreal injection or infusion

DRUG

Ranibizumab

Intravitreal injection

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY